In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Elena Zaklyazminskaya
Elena Zaklyazminskaya Elena Zaklyazminskaya

Petrovsky National Research Center of Surgery, Moscow (Russian Federation)

Specialities : Basic Science , Basic Science, Chronic Heart Failure, Pediatric Cardiology, Risk Factors and Prevention

6 presentations from this speaker

Reverse cardiac remodeling operation in non-ischemic dilated cardiomyopathy patients

Event : HFA Discoveries 2020

  • Session : HFA Discoveries - ePosters
  • Speaker : E Zaklyazminskaya (Moscow,RU)

De novo mutation rate in patients with hypertrophic cardiomyopathy and left ventricular non-compaction.

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : E Zaklyazminskaya (Moscow,RU)

New insight into the clinical polymorphism of SCNA-related arrhythmic syndromes revealed by deep phenotyping

Event : EHRA 2017

  • Session : Late Breaking Science - Poster Session
  • Speaker : E Zaklyazminskaya (Moscow,RU)

Cardiac hypertrophy is associated with mutations in SCN5A gene

Event : ESC Congress 2015

  • Session : Arrhythmias and cardiomyopathies
  • Speaker : E Zaklyazminskaya (Moscow,RU)

Cardiomyopathies associated with mutations in SCN5A gene

Event : EHRA 2015

  • Session : Genetics (Basic Science in Arrhythmias)
  • Speaker : E Zaklyazminskaya (Moscow,RU)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are